Detalhe da pesquisa
1.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler
; 26(13): 1729-1739, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31680631
2.
Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet.
Pharmacoepidemiol Drug Saf
; 27(5): 457-463, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29027301
3.
Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized Controlled Trial.
J Clin Psychiatry
; 85(1)2024 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416865
4.
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
NEJM Evid
; 2(6): EVIDoa2200339, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320129
5.
Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
Psychiatry Res
; 302: 114030, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118485
6.
Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study.
J Clin Psychiatry
; 81(3)2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433835
7.
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.
CNS Drugs
; 34(2): 185-196, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953790